These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7760531)

  • 1. Basic and clinical pharmacology of the acetylcholine receptor: implications for the use of neuromuscular relaxants.
    Martyn JA
    Keio J Med; 1995 Mar; 44(1):1-8. PubMed ID: 7760531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers.
    Martyn JA; White DA; Gronert GA; Jaffe RS; Ward JM
    Anesthesiology; 1992 May; 76(5):822-43. PubMed ID: 1575351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged d-tubocurarine infusion and/or immobilization cause upregulation of acetylcholine receptors and hyperkalemia to succinylcholine in rats.
    Yanez P; Martyn JA
    Anesthesiology; 1996 Feb; 84(2):384-91. PubMed ID: 8602670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged duration of succinylcholine in patients receiving anticonvulsants: evidence for mild up-regulation of acetylcholine receptors?
    Melton AT; Antognini JF; Gronert GA
    Can J Anaesth; 1993 Oct; 40(10):939-42. PubMed ID: 8222033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of neuromuscular blocking agents.
    Fisher DM
    Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S4-9. PubMed ID: 10437710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of acetylcholine receptor loss from the neuromuscular junction.
    Engel AG; Fumagalli G
    Ciba Found Symp; 1982; (90):197-224. PubMed ID: 6923808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental autoimmune myasthenia gravis in the mouse.
    Wu B; Goluszko E; Huda R; Tüzün E; Christadoss P
    Curr Protoc Immunol; 2011 Nov; Chapter 15():Unit 15.23. PubMed ID: 22048803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
    Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A
    Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic defects and disorders at the neuromuscular junction].
    Ohno K
    Brain Nerve; 2011 Jul; 63(7):669-78. PubMed ID: 21747136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
    Lindstrom JM; Einarson BL; Lennon VA; Seybold ME
    J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na+ channel and acetylcholine receptor changes in muscle at sites distant from burns do not simulate denervation.
    Nosek MT; Martyn JA
    J Appl Physiol (1985); 1997 Apr; 82(4):1333-9. PubMed ID: 9104873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex.
    Albuquerque EX; Aracava Y; Cintra WM; Brossi A; Schönenberger B; Deshpande SS
    Braz J Med Biol Res; 1988; 21(6):1173-96. PubMed ID: 3074841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utrophin abundance is reduced at neuromuscular junctions of patients with both inherited and acquired acetylcholine receptor deficiencies.
    Slater CR; Young C; Wood SJ; Bewick GS; Anderson LV; Baxter P; Fawcett PR; Roberts M; Jacobson L; Kuks J; Vincent A; Newsom-Davis J
    Brain; 1997 Sep; 120 ( Pt 9)():1513-31. PubMed ID: 9313636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic acetylcholine receptors in health and disease.
    Lindstrom J
    Mol Neurobiol; 1997 Oct; 15(2):193-222. PubMed ID: 9396010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes.
    Ashizawa T; Elias SB; Appel SH
    Ann Neurol; 1982 Jan; 11(1):22-7. PubMed ID: 6277235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental autoimmune myasthenia gravis in the mouse.
    Wu B; Goluszko E; Huda R; Tüzün E; Christadoss P
    Curr Protoc Immunol; 2013; Chapter 15():Unit 15.8.. PubMed ID: 23392639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of local anesthetics on the inhibition of adult muscle-type nicotinic acetylcholine receptors by nondepolarizing muscle relaxants.
    Wang H; Zhang Y; Li ST
    Eur J Pharmacol; 2010 Mar; 630(1-3):29-33. PubMed ID: 20045405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformation, action, and mechanism of action of neuromuscular blocking muscle relaxants.
    Lee C
    Pharmacol Ther; 2003 May; 98(2):143-69. PubMed ID: 12725867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.